ReviewSynthetic and systems biotechnology2016
A brief overview of synthetic biology research programs and roadmap studies in the United States.
Review in Synthetic and systems biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Bioactive Terpenes from Marine Sponges and Their Associated Organisms.Marine drugs · 2025Review
- Synthetic biology in plants.Plant biotechnology (Tokyo, Japan) · 2024Article
- Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine.Frontiers in bioengineering and biotechnology · 2024Review
- Applications of synthetic biology in medical and pharmaceutical fields.Signal transduction and targeted therapy · 2023Review
- De novo synthesis of synthetic biology ecosystem in Slovakia: Challenges and opportunities.Biotechnology notes (Amsterdam, Netherlands) · 2022Article
- Real-World Synthetic Biology: Is It Founded on an Engineering Approach, and Should It Be?Life (Basel, Switzerland) · 2019Article
- Constructing future scenarios as a tool to foster responsible research and innovation among future synthetic biologists.Life sciences, society and policy · 2018Article
- Scaling up genetic circuit design for cellular computing: advances and prospects.Natural computing · 2018Article
- Cellular reagents for diagnostics and synthetic biology.PloS one · 2018Article
- Synthetic biology in China, UK and US.Synthetic and systems biotechnology · 2016Article
- Tracking the emergence of synthetic biology.ScientometricsArticle
- Bioeconomy in India: Policy, Prospects and Perspective.Engineering biologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The United States is a leading nation in the development of synthetic biology, an emerging engineering discipline to create, control and reprogram biological systems. With strategic investment from its government agencies, the U.S. has established numerous research centers and programs in synthetic biology, enabling significant advances in foundational tool development and practical applications ranging from bioenergy, biomanufacturing, to biomedicine. To maintain its leadership in synthetic biology, U.S, has conducted several roadmap studies to provide strategic visions and action recommendations. Here we will provide a brief overview of the major research programs and roadmap studies of synthetic biology in the U.S.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.